Orum Therapeutics Conference Call: Pipeline Strategy and Next Steps

Written By Allen (Biho) Seo

Orum Therapeutics will hold a conference call to provide an update on its pipeline strategy, including the discontinuation of the ORM-6151 Phase 1 study, plans to advance its IND-cleared ORM-1153 program into a first-in-human Phase 1 trial, and priorities for the broader pipeline.


Event Details
Date: September 23, 2026
Time: 10:00 AM KST Webcast : Register Here

Allen (Biho) Seo
Next

Orum Therapeutics to Participate in NDR Hosted by Mirae Asset